Figure 4From: Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation studyBinary logistic regression plots displaying the frequency of anemia, leukopenia and thrombocytopenia at different therapeutic [90Y-DOTA]-TOC activities (A). Cumulative incidence functions displaying the proportion of patients with renal toxicity are shown for low-dose, intermediate dose and high-dose [90Y-DOTA]-TOC treatment (B). Covariate-adjusted Kaplan-Meier estimates of overall survival are shown for low-dose, intermediate dose and high-dose [90Y-DOTA]-TOC treatment (C).Back to article page